Congress Reinforces PBM Ownership Restrictions to Lower Drug Costs
A new bipartisan Patients Before Monopolies (PBM) Act seeks to ban PBM ownership of pharmacies. This legislation increases regulatory scrutiny and compliance burdens for healthcare contractors, potentially reshaping procurement strategies across the pharmaceutical sector.